These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1878061)

  • 21. Von Willebrand factor improves risk prediction in addition to N-terminal pro-B-type natriuretic peptide in patients referred to coronary angiography and signs and symptoms of heart failure and preserved ejection fraction.
    Kleber ME; Koller L; Goliasch G; Sulzgruber P; Scharnagl H; Silbernagel G; Grammer TB; Delgado G; Tomaschitz A; Pilz S; März W; Niessner A
    Circ Heart Fail; 2015 Jan; 8(1):25-32. PubMed ID: 25342739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preservation of von Willebrand factor multimers and function in patients with an EVAHEART centrifugal-type, continuous-flow left ventricular assist device.
    Ichihara Y; Nishinaka T; Komagamine M; Yamada Y; Yamazaki K
    J Heart Lung Transplant; 2017 Jul; 36(7):814-817. PubMed ID: 28495445
    [No Abstract]   [Full Text] [Related]  

  • 23. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
    Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dynamics of structural functional parameters of cardiovascular system in patients with Stable Angina and Congestive Heart Failure treated with Ivabradine for six months].
    Kosheleva NA; Rebrov AP
    Kardiologiia; 2010; 50(9):34-40. PubMed ID: 21118164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure.
    Gombos T; Makó V; Cervenak L; Papassotiriou J; Kunde J; Hársfalvi J; Förhécz Z; Pozsonyi Z; Borgulya G; Jánoskuti L; Prohászka Z
    Thromb Haemost; 2009 Sep; 102(3):573-80. PubMed ID: 19718479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE).
    Tsai AW; Cushman M; Rosamond WD; Heckbert SR; Tracy RP; Aleksic N; Folsom AR
    Am J Med; 2002 Dec; 113(8):636-42. PubMed ID: 12505113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venous thromboembolism in von Willebrand disease.
    Mannucci PM
    Thromb Haemost; 2002 Sep; 88(3):378-9. PubMed ID: 12353063
    [No Abstract]   [Full Text] [Related]  

  • 28. Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation.
    Lip GY; Lane D; Van Walraven C; Hart RG
    Stroke; 2006 Sep; 37(9):2294-300. PubMed ID: 16888271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
    Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA
    Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Von Willebrand factor and mitral valve prolapse.
    Froom P; Margulis T; Grenadier E; Palant A; David M; Aghai E
    Thromb Haemost; 1988 Oct; 60(2):230-1. PubMed ID: 3265226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are increased levels of von Willebrand factor in chronic coronary heart disease caused by decrease in von Willebrand factor cleaving protease activity? A study by an immunoassay with antibody against intact bond 842Tyr-843Met of the von Willebrand factor protein.
    He S; Cao H; Magnusson CG; Eriksson-Berg M; Mehrkash M; Schenck-Gustafsson K; Blombäck M
    Thromb Res; 2001 Aug; 103(3):241-8. PubMed ID: 11672586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thromboembolic incidence with transiently elevated levels of coagulation factors in patients with von Willebrand disease treated with VWF:FVIII concentrate during surgery.
    Gill JC; Mannucci PM
    Haemophilia; 2014 Nov; 20(6):e404-6. PubMed ID: 25113065
    [No Abstract]   [Full Text] [Related]  

  • 33. Thromboembolism and antithrombotic therapy in congestive heart failure.
    Dunkman WB
    J Cardiovasc Risk; 1995 Apr; 2(2):107-17. PubMed ID: 7606647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma levels of von Willebrand factor and plasminogen activator in patients with arterial thromboembolism--with special reference to their correlation to the increased catabolism of both fibrinogen and platelets.
    Matsumoto M; Uchiyama T; Kobayashi N; Maekawa T
    Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1105-14. PubMed ID: 2588960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Von Willebrand factor and aging.
    Konkle BA
    Semin Thromb Hemost; 2014 Sep; 40(6):640-4. PubMed ID: 25151524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perioperative onset of acquired von Willebrand syndrome: Comparison between HVAD, HeartMate II and on-pump coronary bypass surgery.
    Feldmann C; Zayat R; Goetzenich A; Aljalloud A; Woelke E; Maas J; Tewarie L; Schmitz-Rode T; Autschbach R; Steinseifer U; Moza A
    PLoS One; 2017; 12(2):e0171029. PubMed ID: 28234916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma levels of von Willebrand factor in subjects with isolated impaired fasting glucose.
    Coban E; Bostan F
    Med Sci Monit; 2009 Apr; 15(4):CR194-7. PubMed ID: 19333205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of tamoxifen on von Willebrand factor levels.
    Ounnoughène N; Molho P; Stieltjes N; Sultan Y
    Arch Intern Med; 1997 Jul; 157(14):1613. PubMed ID: 9236565
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasma and platelet von Willebrand factor defects in uremia.
    Gralnick HR; McKeown LP; Williams SB; Shafer BC; Pierce L
    Am J Med; 1988 Dec; 85(6):806-10. PubMed ID: 3264111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma YKL-40 levels are elevated in patients with chronic heart failure.
    Rathcke CN; Kistorp C; Raymond I; Hildebrandt P; Gustafsson F; Lip GY; Faber J; Vestergaard H
    Scand Cardiovasc J; 2010 Apr; 44(2):92-9. PubMed ID: 19961288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.